Platelet-rich plasma injections for tendinopathy and osteoarthritis

International Journal of Clinical Rheumatology

Volumn 7, Issue 4, 2012, Pages 397-412

  Andia, Isabel ^a   Abate, Michele ^b  

^a BIOCRUCES BIZKAIA HEALTH RESEARCH INSTITUTE   (Spain)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

angiogenesis; cytokines; growth factors; inflammation; injection therapies; osteoarthritis; platelet rich plasma; tendinopathy

Indexed keywords

ARTICLE; BIOLOGICAL ACTIVITY; CELL COMPOSITION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CYTOKINE RELEASE; ENZYME ACTIVATION; HUMAN; IMMUNOMODULATION; OSTEOARTHRITIS; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; QUALITY OF LIFE; SIGNAL TRANSDUCTION; TENDINITIS; THERAPY EFFECT; THROMBOCYTE RICH PLASMA;

EID: 84865335109     PISSN: 17584272     EISSN: 17584280     Source Type: Journal    
DOI: 10.2217/ijr.12.36     Document Type: Article

References (86)

1. Fanelli GC, Orcutt DR, Harris JD. The athletically active middle aged arthritic knee: Introduction, demographics, sports participation epidemiology and types of injuries seen. Sports Med. Arthroscop. Rev. 11(2), 98-101 (2003
2. Paalova M, Kannus P, Järvinen M. Epidemiology of tendon problems in sports. In: Tendon Injuries: Basic Science and Clinical Medicine. Maffulli N, Renstrom P, Leadbetter W (Eds). Springer, London, UK (2005
3. Brown TD, Johnston RC, Saltzman CL et al. Posttraumatic osteoarthritis: A first estimate of incidence, prevalence, and burden of disease. J. Orthop. Trauma 20(10), 739-744 (2006
4. Sanchez M, Anitua E, Orive G, Mujika I, Andia I. Platelet-rich therapies in the treatment of orthopaedic sport injuries. Sports Med. 39, 345-354 (2009
5. Andia, I, Sanchez, M, Maffulli N. Tendon healing and platelet-rich plasma therapies. Expert Opin. Biol. Ther. 10, 1415-1426 (2010
6. Andia I, Sánchez M, Maffulli N. Joint pathology and platelet-rich plasma therapies. Expert Opin. Biol. Ther. 12(1), 7-22 (2012
7. Anitua E, Sanchez M, Orive G, Andia I. The potential impact of the preparations rich in growth factors (PRGF) in different medical fields. Biomaterials 28(31), 4551-4560 (2007
8. Blair P, Flaumenhaft R. Platelet a-granules: Basic biology and clinical correlates. Blood Rev. 23(4), 177-189 (2009
9. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb. Haemost. 105(Suppl. 1), S13-S33 (2011
10. Mazzocca AD, McCarthy MB, Chowaniec DM et al. Platelet-rich plasma differs according to preparation method and human variability. J. Bone Joint Surg. Am. 94(4), 308-316 (2012
11. Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am. J. Sports Med. 39(10), 2135-2140 (2011
12. Castillo TN, Pouliot MA, Kim HJ, Dragoo JL. Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am. J. Sports Med. 39(2), 266-271 (2011
13. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 27(3), 158-167 (2009
14. Dohan Ehrenfest DM, Bielecki T, Mishra A et al. In search of a consensus terminology in the field of platelet concentrates for surgical use: Platelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization and leukocytes. Curr. Pharm. Biotech. 12, 1-7 (2012
15. Maynard DM, Heijnen HFG, Horme MK et al. Proteomic analysis of platelet a-granules using mass spectrometry. J. Thromb. Haemost. 5(9), 1945-1955 (2005
16. Borregaard N, Sorensen OE, Theilgaard- Mönch K. Neutrophil granules: A library of innate immunity proteins. Trends Immunol. 28(8), 340-345 (2007
17. Nathan C. Neutrophils and immunity: Challenges and opportunities. Nat. Rev. Immunol. 6(3), 173-182 (2006
18. Harrison S, Vavken P, Kevy S, Jacobson M, Zurakowski D, Murray MM. Platelet activation by collagen provides sustained release of anabolic cytokines. Am. J. Sports Med. 39(4), 729-734 (2011
19. Scherer SS, Tobalem M, Vigato E et al. Nonactivated versus thrombin-activated platelets on wound healing and fibroblast-to-myofibroblast differentiation in vivo and in vitro. Plast. Reconstr. Surg. 129(1), 46e-54e (2011
20. Ma L, Perini R, McKnight W et al. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets. Proc. Natl Acad. Sci. USA 102(1), 216-220 (2005
21. Harrison S, Vavken P, Kevy S, Jacobson M, Zurakowski D, Murray MM. Platelet activation by collagen provides sustained release of anabolic cytokines. Am. J. Sports Med. 39(4), 729-734 (2011
22. Anitua E, Andia I, Sanchez M et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J. Orthop. Res. 23(2), 281-286 (2005
23. Semple JW, Italiano JE, Freedman J. Platelets and the immune continuum. Nat. Rev. Immunol. 11, 264-274 (2011
24. Flad HD, Brandt E. Platelet-derived chemokines: Pathophysiology and therapeutic aspects. Cell. Mol. Life Sci. 67(14), 2363-2386 (2010
25. El-Sharkawy H, Kantarci A, Deady J et al. Platelet-rich plasma: Growth factors and pro-and anti-inflammatory properties. J. Periodontol. 78(4), 661-669 (2007
26. Vandercapellen J, Van Damme J, Struyf S. The role of CXC chemokines platelet factor-4 (CXCL4/PF4) and its variant (CXCLaL1/PF-avar) in inflammation, angiogenesis and cancer. Cytokine Growth Factors Rev. 22(1), 1-18 (2010
27. Gleissner CA, Shaked I, Little KM, Ley K. CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages. J. Immunol. 184(9), 4810-4818 (2010
28. Bendinelli P, Matteucci E, Dogliotti G et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: Mechanisms of NF-kB inhibition via HGF. J. Cell. Physiol. 225(3), 757-766 (2010
29. Walshe TE, Saint-Geniez M, Maharaj ASR et al. TGF-b is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature. PloS ONE 4(4), e5149 (2009
30. Nakamura T, Sakai K, Nakamura T, Matsumoto K. Hepatocyte growth factor twenty years on: Much more than a growth factor. J. Gastroenterol. Hepatol. 26(Suppl. 1), S188-S202 (2011
31. Coudriet GM, He J, Trucco M et al. Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: Implications for inflammatory mediated diseases. PloS ONE 5(11), e15384 (2010
32. Dragoo JL, Braun HJ, Durham JL et al. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. Am. J. Sports Med. 40(6), 1274-1281 (2012
33. Filardo G, Kon E, Pereira Ruiz MT et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: Single- versus double-spinning approach. Knee Surg. Sports Traumatol. Arthrosc. doi:10.1007/ s00167-011-1837-x (2012) (Epub ahead of print
34. van Buul GM, Koevoet WL, Kops N et al. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocyte. Am. J. Sports Med. 39(11), 2362-2370 (2011
35. Lippross S, Moeller B, Haas H et al. Intraarticular injection of platelet-rich plasma reduces inflammation in a pig model of rheumatoid arthritis of the knee joint. Arthritis Rheum. 63(11), 3344-3353 (2011
36. Stellos K, Gnerlich S, Kraemer B, Lindemann S, Gawaz M. Platelet interaction with progenitor cells: Vascular regeneration or inquiry? Pharmacol. Rep. 60(1), 101-108 (2008
37. von Hundelshausen P, Petersen F, Brandt E. Platelet-derived chemokines in vascular biology. Thromb. Haemost. 97(5), 704-713 (2007
38. Bi Y, Eirchiou D, Kilts TM et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat. Med. 13(10), 1219-1227 (2007
39. Zhang J, Wang JH. Platelet rich plasma releasate promotes differentiation of tendon stem cells into active tenocytes. Am. J. Sports Med. 38(12), 2477-2482 (2010
40. Chen L, Dong SW, Liu JP, Tao X, Tang KL, Xu JZ. Synergy of tendon stem cells and platelet rich plasma in tendon healing. J. Orthop. Res. 30(6), 991-997 (2011
41. Wang X, Qiu Y, Triffit J, Carr A, Xia Z, Sabokbar A. Proliferation and differentiation of human tenocytes in response to platelet rich plasma: An in vitro and in vivo study. J. Orthop. Res. 30(6), 982-990 (2011
42. Krüger JP, Hondke S, Endres M, Pru; A, Siclari A, Kaps C. Human platelet-rich plasma stimulates migration and chondrogenic differentiation of human subchondral progenitor cells. J. Orthop. Res. 30(6), 845-852 (2011
43. Milano G, Deriu L, Passino ES et al. Repeated platelet concentrate injections enhance reparative response of microfractures in the treatment of chondral defects of the knee: An experimental study in an animal model. Arthroscopy 28(5), 688-701 (2012
44. Karistinou A, Dell'Accio F, Kurth TB et al. Distinct mesenchymal progenitor cell subsets in the adult human synovium. Rheumatology 48(9), 1057-1064 (2009
45. Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat. Rev. Rheumatol. 6(11), 625-635 (2010
46. Ashraf S, Walsh DA. Angiogenesis in osteoarthritis. Curr. Opin. Rheumatol. 20, 573-580, (2008
47. Felson DT. Developments in the clinical understanding of osteoarthritis. Arthritis Res. Ther. 11(1), 203-214 (2009
48. Anitua E, Sanchez M, Nurden AT et al. Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology 46(12), 1769-1772 (2007
49. Sánchez M, Guadilla J, Fiz N, Andia I. Ultrasound-guided platelet rich plasma injections for the treatment of osteoarthritis of the hip. Rheumatology (Oxford) 51(1), 144-150 (2012
50. Battaglia M, Guaraldi F, Vannini F et al. Platelet-rich plasma (PRP) intra-articular ultrasound-guided injections as a possible treatment for hip osteoarthritis: A pilot study. Clin. Exp. Rheumatol. 29(4), 754 (2011
51. Mei-Dan O, Carmont MR, Laver L, Mann G, Maffulli N, Nyska M. Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am. J. Sports Med. 40(3), 534-541 (2012
52. Wang-Saegusa A, Cugat R, Ares O et al. Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life. Arch. Orthop. Trauma Surg. 131(3), 311-317 (2011
53. Sampson S, Reed M, Silvers H et al. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis a pilot study. Am. J. Phys. Med. Rehabil. 89(12), 961-969 (2010
54. Gobbi A, Karantzikos G, Mahajan V, Malchira S. Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: Preliminary results in a group of active patients. Sports Health doi:10.1177/1941738111431801 (2012) (Epub ahead of print
55. Kon E, Buda R, Filardo G et al. Platelet-rich plasma: Intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg. Sports Traumatol. Arthrosc. 18(4), 472-479 (2010
56. Napolitano M, Matera S, Bossio M et al. Autologous platelet gel for tissue regeneration in degenerative disorders of the knee. Blood Transfus. 10(1), 72-77 (2012
57. Filardo G, Kon E, Buda R et al. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg. Sports Traumatol. Arthrosc. 19(4), 528-535 (2011
58. Kon E, Mandelbaum B, Buda R et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: From early degeneration to osteoarthritis. Arthroscopy 27(11), 1490-1501 (2011
59. Spaková T, Rosocha J, Lacko M, Harvanová D, Gharaibeh A. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am. J. Phys. Med. Rehabil. 91(4), 1-7 (2012
60. Sanchez M, Anitua E, Azofra J, Aguirre JJ, Andia I. Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: A retrospective cohort study. Clin. Exp. Rheumatol. 26(5), 910-913 (2008
61. Silbernagel KG, Brorsson A, Lundberg M. The majority of patients with Achilles tendinopathy recover fully when treated with exercise alone: A 5-year follow-up. Am. J. Sports Med. 39(3), 607-613 (2011
62. Abate M, Silbernagel KG, Siljeholm C et al. Pathogenesis of tendinopathies: Inflammation or degeneration? Arthritis Res. Ther. 11(3), 235 (2009
63. Langberg H, Ellingsgaard H, Madsen T et al. Eccentric rehabilitation exercise increases peritendinous type I collagen synthesis in humans with Achilles tendinosis. Scand. J. Med. Sci. Sports 17, 61-66 (2007
64. Corps AN, Jones GC, Harrall RL, Curry VA, Hazleman BL, Riley GP. The regulation of aggrecanase ADAMTS-4 expression inhuman Achilles tendon and tendon-derived cells. Matrix Biol. 27(5), 393-401 (2008
65. Fredberg U, Stengaard-Pedersen K. Chronic tendinopathy tissue pathology, pain mechanisms, and etiology with a special focus on inflammation. Scand. J. Med. Sci. Sports 18(1), 3-15 (2008
66. Petersen W, Pufe T, Zantop T, Tillmann B, Mentlein R. Hypoxia and PDGF have a synergistic effect that increases the expression of the angiogenetic peptide vascular endothelial growth factor in Achilles tendon fibroblasts. Arch. Orthop. Trauma Surg. 123(9), 485-488 (2003
67. Pufe T, Petersen WJ, Mentlein R, Tillmann BN. The role of vasculature and angiogenesis for the pathogenesis of degenerative tendons disease. Scand. J. Med. Sci. Sports 15(4), 211-222 (2005
68. Forsgren S, Danielson P, Alfredson H. Vascular NK-1 receptor occurrence in normal and chronic painful Achilles and patellar tendons: Studies on chemically unfixed as well as fixed specimens. Regul. Pept. 126(3), 173-181 (2005
69. Andersson G, Danielson P, Alfredson H, Forsgren S. Presence of substance P and the neurokinin-1 receptor in tenocytes of the human Achilles tendon. Regul. Pept. 150(1-3), 81-87 (2008
70. Renstrom PAHF, Woo SL-Y. Tendinopathy: A major medical problem in sport. In: Tendinopathy in Athletes. Woo SL-Y, Renstrom PAHF, Arnoczky SP (Eds). Blackwell Publishing Ltd, Oxford, UK, 1-9 (2008
71. Volpi P, Marinoni L, Bait C, De Girolamo L, Schoenhuber H. Treatment of chronic patellar tendinosis with buffered platelet rich plasma: A preliminary study. Med. Sport 60, 595-603 (2007
72. Volpi P, Quaglia A, Schoenhuber H et al. Growth factors in the management of sport-induced tendinopathies: Results after 24 months from treatment. A pilot study. J. Sports Med. Phys. Fitness 50(4), 494-500 (2010
73. Kon E, Filardo G, Delcogliano M et al. Platelet rich-plasma: New clinical application: A pilot study for treatment of jumper's knee. Injury 40(6), 598-603 (2009
74. Gaweda K, Tarczynska M, Krzyzanowski W. Treatment of Achilles tendinopathy with platelet-rich plasma. Int. J. Sports Med. 31(8), 577-583 (2010
75. Barrett S, Erredge S. Growth factors for chronic plantar fasciitis. Podiatry Today 17, 37-42 (2004
76. Finnoff JT, Fowler SP, Lai JK et al. Treatment of chronic tendinopathy with ultrasound-guided needle tenotomy and platelet-rich plasma injection. Platin. Met. Rev. 3(10), 900-911 (2011
77. Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: Platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am. J. Sports Med. 38(2), 255-262 (2010
78. Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: A double-blind randomized controlled trial with 2-year follow-up. Am. J. Sports Med. 39(6), 1200-1208 (2011
79. Creaney L, Walla A, Curtis M, Connell D. Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: A prospective, double-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections. Br. J. Sports Med. 45(12), 966-971 (2011
80. Thanasas C, Papadimitriou G, Charalambidis C, Paraskevopoulos I, Papanikolaou A. Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: A randomized controlled clinical trial. Am. J. Sports Med. 39(10), 2130-2134 (2011
81. Zargar Bablodashti N, Poulsen RC, Franklin SL, Thompson MS, Hulley PA. Platelet-rich plasma protects tenocytes form adverse side effects of dexamethasone and ciprofloxacin. Am. J. Sports Med. 39(9), 1929-1935 (2011
82. de Vos RJ, Weir A, van Schie HT et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: A randomized controlled trial. JAMA 303(2), 144-149 (2010
83. de Jonge S, de Vos RJ, Weir A et al. One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: A double-blind randomized placebo-controlled trial. Am. J. Sports Med. 39(8), 1623-1629 (2011
84. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am. J. Sports Med. 34(11), 1774-1778 (2006
85. Carofino B, Chowaniec DM, McCarthy MB et al. Corticosteroids and local anesthetics decrease positive effects of platelet-rich plasma: An in vitro study on human tendon cells. Arthroscopy 28(5), 711-719 (2012
86. Filardo G, Kon E, Della Villa S, Vincentelli F, Fornasari PM, Marcacci M. Use of platelet-rich plasma for the treatment of refractory jumper's knee. Int. Orthop. 34(6), 909-915 (2010